LT - USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES FOR THE TREATMENT OF MYELOMA
EN - USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES FOR THE TREATMENT OF MYELOMA
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
A61K 31/519 |
|
|
|
A61P 35/00 |
|
European patent
| (11) |
Number of the document |
2344164 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
09778466.4 |
|
Date of filing the European patent application |
2009-09-11 |
| (97) |
Date of publication of the European application |
2011-07-20 |
| (45) |
Date of publication and mention of the grant of the patent |
2015-07-15
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/EP2009/006586 |
|
Date |
2009-09-11 |
PCT application publication
| (87) |
Number |
WO 2010/034414 |
|
Date |
2010-04-01 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
08164988 |
2008-09-24
|
EP |
Inventors
| (72) |
LIU, Ningshu, DE
|
Grantee
| (73) |
Bayer Intellectual Property GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
Title
| (54) |
USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES FOR THE TREATMENT OF MYELOMA |
| |
USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES FOR THE TREATMENT OF MYELOMA |
